[go: up one dir, main page]

EP1292189A4 - Oral gram (+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal - Google Patents

Oral gram (+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal

Info

Publication number
EP1292189A4
EP1292189A4 EP01937205A EP01937205A EP1292189A4 EP 1292189 A4 EP1292189 A4 EP 1292189A4 EP 01937205 A EP01937205 A EP 01937205A EP 01937205 A EP01937205 A EP 01937205A EP 1292189 A4 EP1292189 A4 EP 1292189A4
Authority
EP
European Patent Office
Prior art keywords
gastro
intestinal
bacteria
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP01937205A
Other languages
German (de)
French (fr)
Other versions
EP1292189A2 (en
Inventor
Pinaki Panigrahi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Maryland Baltimore
University of Maryland College Park
Original Assignee
University of Maryland Baltimore
University of Maryland College Park
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Maryland Baltimore, University of Maryland College Park filed Critical University of Maryland Baltimore
Publication of EP1292189A2 publication Critical patent/EP1292189A2/en
Publication of EP1292189A4 publication Critical patent/EP1292189A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
EP01937205A 2000-05-03 2001-05-03 Oral gram (+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal Withdrawn EP1292189A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20140800P 2000-05-03 2000-05-03
US201408P 2000-05-03
PCT/US2001/014080 WO2001083700A2 (en) 2000-05-03 2001-05-03 Oral gram(+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal

Publications (2)

Publication Number Publication Date
EP1292189A2 EP1292189A2 (en) 2003-03-19
EP1292189A4 true EP1292189A4 (en) 2003-08-13

Family

ID=22745700

Family Applications (1)

Application Number Title Priority Date Filing Date
EP01937205A Withdrawn EP1292189A4 (en) 2000-05-03 2001-05-03 Oral gram (+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal

Country Status (4)

Country Link
EP (1) EP1292189A4 (en)
AU (1) AU2001262966A1 (en)
CA (1) CA2407724A1 (en)
WO (1) WO2001083700A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0114419D0 (en) * 2001-06-13 2001-08-08 Mars Uk Ltd Health food
SE526711C2 (en) 2003-01-31 2005-10-25 Probi Ab Novel strains of Bifidobacterium having ability to survive in intestinal tract and produce glutamine and arginine in vivo, useful for preparing medicament for treatment of intensive care patients with intestinal failure

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007808A (en) * 1995-06-23 1999-12-28 Dibra S.P.A. Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5533973A (en) * 1995-01-13 1996-07-09 Abbott Laboratories Alteration of nutritional product during enteral tube feeding
US5707353A (en) * 1995-12-21 1998-01-13 Abbott Laboratories Oral administration of beneficial agents
US6132710A (en) * 1997-03-17 2000-10-17 Probiotix, Inc. Preventing/treating neonatal NEC by administering lactobacillus salivarius and lactobacillus plantarum or a combination thereof
US5981590A (en) * 1997-03-17 1999-11-09 Probiotix, Inc. Oral glutamine in the prevention of neonatal necrotizing enterocolitis and other gastrointestinal mucosal damage
US6203797B1 (en) * 1998-01-06 2001-03-20 Stephen C. Perry Dietary supplement and method for use as a probiotic, for alleviating the symptons associated with irritable bowel syndrome
US6262019B1 (en) * 1998-04-30 2001-07-17 Vit-Immune, L. C. Method of treatment of glutathione deficient mammals
US6156355A (en) * 1998-11-02 2000-12-05 Star-Kist Foods, Inc. Breed-specific canine food formulations

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6007808A (en) * 1995-06-23 1999-12-28 Dibra S.P.A. Pharmaceutical and diet formulations for the prophylaxis and treatment of gastrointestinal disorders

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ROTH E ET AL: "GLUTAMIN: WIRKUNGEN AUF DAS IMMUNOSYSTEM, AUF EIWEISSHAUSHALT UND DARMFUNKTIONEN", WIENER KLINISCHE WOCHENSCHRIFT, NEW YORK, NY, US, vol. 108, no. 21, 1996, pages 669 - 676, XP000937773, ISSN: 0043-5325 *

Also Published As

Publication number Publication date
EP1292189A2 (en) 2003-03-19
AU2001262966A1 (en) 2001-11-12
WO2001083700A3 (en) 2002-02-07
CA2407724A1 (en) 2001-11-08
WO2001083700A2 (en) 2001-11-08

Similar Documents

Publication Publication Date Title
AU2001239052A1 (en) Compositions for prevention and treatment of dementia
IL245955B (en) Immunogenic compositions for the prevention and treatment of meningococcal disease
IL146703A0 (en) Dietary of pharmaceutical composition for use for the prevention or treatment of hyperoxaluria
HUP0103920A3 (en) Methods and compositions for the prevention and treatment of anemia
AUPR105400A0 (en) Processes and compositions for water treatment
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
EP1461024A4 (en) Treatment of wounds and compositions employed
IL152553A0 (en) Compounds and methods for the treatment and prevention of bacterial infection
IL156770A0 (en) Methods employing and compositions containing plaque associated molecules for prevention and treatment of atherosclerosis
EP1181011A4 (en) Compositions and methods for treatment of staphylococcal infection
HUP0302309A3 (en) Method for locating compounds which are suitable for the treatment and/or prophylaxis of obesity and for preparation of pharmaceutical compositions containing them
EP1292189A4 (en) Oral gram (+) bacteria and glutamine composition for prevention and/or treatment of gastro-intestinal
AUPR809001A0 (en) Compositions for the treatment and prevention of plant pathogens
IL154354A0 (en) Composition for prophylaxis and treatment of cancer
AU2002303552A8 (en) Methods and compositions for prevention of angioproliferation
IL151403A0 (en) Compositions and methods for treatment of epilepsy
AU4034800A (en) Novel compositions and methods for prevention and treatment of protozoal disease
EP1305017A4 (en) Methods and compositions for the prevention and treatment of syndrome x
MXPA03006468A (en) Compositions for prevention or treatment of hepatopathy.
AU2002226682A1 (en) Compositions for prevention or treatment of hepatopathy
HU9902759D0 (en) Process and composition for prevention and treatment of cancer
SI1305286T1 (en) Cyclopentanoindoles, compositions containing such compounds and methods of treatment
AU2001281747A1 (en) Composition and method for the treatment or prevention of hiv infection
AUPQ501000A0 (en) Compositions for the prevention and treatment of influenza
ZA200102583B (en) Methods and compositions for the prevention and treatment of anemia

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20021203

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

AX Request for extension of the european patent

Extension state: AL LT LV MK RO SI

A4 Supplementary search report drawn up and despatched

Effective date: 20030702

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20041201